Clinical observation and nursing intervention of prednisone acetate combined with leflunomide in the treatment of IgA nephropathy
10.3969/j.issn.1005-1678.2017.09.131
- VernacularTitle:醋酸泼尼松联合来氟米特治疗IgA肾病的临床观察及护理措施
- Author:
Wanqing LIN
;
Yuehua ZHANG
;
Hui WANG
- Keywords:
prednisone acetate;
leflunomide;
IgA nephropathy;
clinical effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):295-296
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study and analyze the clinical observation and nursing measures of prednisone acetate combined leflunomide in the treatment of IgA nephropathy.Methods 100 patients with IgA nephropathy treated in our hospital from February 2015 to September 2016 were randomly divided into the control group and the experimental group,with 50 patients in each group.Patients in the control group were treated with prednisone and dropped to 0.5 mg/kg after 12 weeks.The patients in the experimental group were treated with leflunomide and dropped to 20 mg after 3 days.The patients in the experimental group and the control group were treated for 3 months.The two groups of patients were given reasonable nursing measures, and compared the treatment effect.Results The effective rate of treatment in the experimental group was 94.0％, significantly higher than that in the control group (64.0％),with statistical difference(P<0.05).After treatment,the level of 24 hours proteinuria in the experimental group was (0.541±0.322)g/L, significantly lower than that of the control group (1.516±0.568)g/L,with statistical difference (P<0.05) .The adverse reaction rate of the experimental group was 0％, and that of the control group was 8％,with statistical difference(P<0.05).Conclusion Prednisone acetate combined leflunomide was effective in the treatment of IgA nephropathy, and can significantly improve the efficiency of treatment, and has clinical significance.
